Company intelligence
Polaroid Therapeutics
Innovative antimicrobial solutions
About Polaroid Therapeutics
Polaroid Therapeutics, founded in 2022, is a healthcare company focused on developing innovative antimicrobial solutions for wound healing and additional indications with unmet medical needs. As a spinoff of Polaroid Sciences, our mission is to bring to life the best of Polaroid's vision of creating a more human and meaningful world through cutting-edge technology and research. Our proprietary technology is designed to address major challenges in antimicrobial therapies and improve patient outcomes. We are committed to positively impacting the lives of patients and their families by delivering superior treatments that prevent, heal, and improve the quality of life. We aspire to reach and help all humankind around the globe.
Verified activity
Signals from Polaroid Therapeutics
3 published signals
Presence & Recognition
Polaroid Therapeutics was featured in the Daily Mail's annual UK university rankings as part of its profile on the University of Hull's £48 million Wound Innovation Institute.
Reported by Polaroid Therapeutics
Research & Knowledge
Polaroid Therapeutics is preparing to work with the University of Hull Wound Innovation Institute on a UK evaluation programme involving more than 100 patients
Reported by Polaroid Therapeutics
Legal & Regulatory
Polaroid Therapeutics received MHRA approval for POLTX_Fiber™ for the UK
Reported by Polaroid Therapeutics